Bioiron 2013: From basic science to medicine

描述（由申请人提供）：我们正在申请资金，以帮助支持2013年4月14日至4月18日在英国伦敦举行的Bioiron 2013会议。我们预计有450-500名参与者，其中2/3将是年轻的研究者。这些资金将用于资助20名年轻的美国研究人员、博士后和学生参加会议，他们将根据杰出的摘要选出。这项投资的目的是促进美国对铁相关疾病的病因、诊断和治疗的研究。获奖者将由全球铁生物学领域的顶尖科学家组成的组委会选出。年轻研究人员将被定义为40岁以下的科学家，他们没有担任过ro1型资助或同等财政资助的主要研究人员。生物铁会议是全面介绍和讨论铁生物学、铁相关疾病（铁超载失调、铁限制性贫血等）以及与这些疾病相关的诊断和治疗的前沿进展的主要国家和国际论坛。该会议每两年举行一次，轮流在铁生物学研究项目最活跃、能提供合适会议设施的大洲和国家举行。Bioiron 2013的组织者致力于确保来自世界各地的科学家的广泛参与，无论其国籍、性别、种族或其他个人特征。铁生物学的健康相关方面将是2013年会议的首要任务。NIH、NIDDK和NHLBI的优先事项在规划本次会议时被特别考虑。除了对最先进的铁病理生物学的广泛概述外，2013年计划将特别强调铁诊断和治疗的最新进展，铁相关疾病的发病机制，以及铁在包括地中海贫血、肠道感染和疟疾在内的全球健康问题中的作用。

DESCRIPTION (provided by applicant): We are requesting funds to help support the Bioiron 2013 Conference in London, UK, scheduled for April 14 to April 18, 2013. We expect 450-500 participants of whom 2/3 will be young investigators. The funds will be used to subsidize conference participation by twenty young US investigators, post-doctoral fellows and students, selected on the basis of outstanding abstracts. The objective of this investment is to advance research on the causes, diagnosis and treatment of iron-related diseases in the US. The awardees will be selected by the Organizing Committee consisting of the leading scientists in the field of iron biology worldwide. Young investigators will be defined as scientists under 40 who have not acted as principal investigators on an RO1-type grant or its financial equivalent. The Bioiron conference is the main national and international forum for comprehensive presentation and discussion of cutting-edge advances in iron biology, iron-related diseases (iron overload disorders, iron-restrictive anemias, and others), and diagnostics and therapies related to these diseases. The conference has taken place every two years, rotating between continents and countries that have the most active research programs in iron biology and can provide suitable conference facilities. The organizers of Bioiron 2013 are committed to assuring broad participation by scientists from all over the world regardless of national origin, gender, race or other personal characteristics. The health- related aspects of iron biology will be the primary priority of the 2013 conference. NIH, NIDDK and NHLBI priorities are specifically taken into account in planning this conference. In addition to a broad overview of state-of-the-art iron pathobiology, the 2013 program will specifically highlight recent advances in iron diagnostics and therapeutics, pathogenesis of iron-related diseases, and the role of iron in global health problems including thalassemias, enteric infection and malaria.